Literature DB >> 17444584

Amitriptyline to relieve pain in juvenile idiopathic arthritis: a pilot study using Bayesian metaanalysis of multiple N-of-1 clinical trials.

Adam M Huber1, George A Tomlinson, Gideon Koren, Brian M Feldman.   

Abstract

OBJECTIVE: Using serial N-of-1 trials and subsequent analysis with Bayesian methods may allow study of therapies using small numbers of subjects. Our research questions were: (1) Can serial N-of-1 trials analyzed with Bayesian statistical techniques be used to estimate the population effect of a therapeutic intervention? (2) Compared to placebo, how likely is it that low-dose amitriptyline therapy in children aged 10-18 years with active polyarticular-course juvenile idiopathic arthritis (JIA) results in a significant improvement in pain?
METHODS: Six children (age 10.3-16.3 yrs, 4 girls) were enrolled. There were 3 pairs of randomized, double-blinded treatments (amitriptyline 25 mg or placebo) per participant. Each treatment lasted 2 weeks, with a 1 week washout. The primary outcome was pain, measured by 10 cm visual analog scale. Assessments were at the beginning and end of each treatment. A Bayesian statistical model was used to determine the treatment effect. Values < 0 indicated superiority of amitriptyline.
RESULTS: Bayesian techniques were used successfully to obtain estimates of population effect, despite the small number of participants. The mean treatment effect for pain was 0.67 (SD 0.89, 95% credible interval -0.99, 2.55). The probability that the treatment effect was < 0 was only 16%.
CONCLUSION: These methods can be used successfully to estimate population effects when sample sizes are small. It is unlikely that amitriptyline reduced pain by a clinically significant amount in these children with polyarticular JIA. These methods may be particularly suited to pilot studies and the study of rare illnesses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17444584

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

Review 1.  Antidepressants for chronic non-cancer pain in children and adolescents.

Authors:  Tess E Cooper; Lauren C Heathcote; Jacqui Clinch; Jeffrey I Gold; Richard Howard; Susan M Lord; Neil Schechter; Chantal Wood; Philip J Wiffen
Journal:  Cochrane Database Syst Rev       Date:  2017-08-05

2.  The landscape of comparative effectiveness research in rheumatology.

Authors:  Esi Morgan DeWitt; Hermine I Brunner
Journal:  Nat Rev Rheumatol       Date:  2013-09-24       Impact factor: 20.543

3.  Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials.

Authors:  Bas C Stunnenberg; Joost Raaphorst; Hans M Groenewoud; Jeffrey M Statland; Robert C Griggs; Willem Woertman; Dick F Stegeman; Janneke Timmermans; Jaya Trivedi; Emma Matthews; Christiaan G J Saris; Bas J Schouwenberg; Gea Drost; Baziel G M van Engelen; Gert Jan van der Wilt
Journal:  JAMA       Date:  2018-12-11       Impact factor: 56.272

Review 4.  Multicrossover Randomized Controlled Trial Designs in Alzheimer Disease.

Authors:  Steven E Arnold; Rebecca A Betensky
Journal:  Ann Neurol       Date:  2018-08-29       Impact factor: 10.422

Review 5.  Drugs for chronic pain in children: a commentary on clinical practice and the absence of evidence.

Authors:  Marie-Claude Grégoire; G Allen Finley
Journal:  Pain Res Manag       Date:  2013 Jan-Feb       Impact factor: 3.037

6.  Systemic Sclerosis Trial Design Moving Forward.

Authors:  Sindhu R Johnson; Dinesh Khanna; Yannick Allanore; Marco Matucci-Cerinic; Daniel E Furst
Journal:  J Scleroderma Relat Disord       Date:  2018-01-23

7.  N-of-1 Randomized Intervention Trials in Health Psychology: A Systematic Review and Methodology Critique.

Authors:  Jonathan A Shaffer; Ian M Kronish; Louise Falzon; Ying Kuen Cheung; Karina W Davidson
Journal:  Ann Behav Med       Date:  2018-08-16

8.  The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?

Authors:  Elizabeth O Lillie; Bradley Patay; Joel Diamant; Brian Issell; Eric J Topol; Nicholas J Schork
Journal:  Per Med       Date:  2011-03       Impact factor: 2.512

9.  Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol.

Authors:  Bas C Stunnenberg; Willem Woertman; Joost Raaphorst; Jeffrey M Statland; Robert C Griggs; Janneke Timmermans; Christiaan G Saris; Bas J Schouwenberg; Hans M Groenewoud; Dick F Stegeman; Baziel G M van Engelen; Gea Drost; Gert Jan van der Wilt
Journal:  BMC Neurol       Date:  2015-03-25       Impact factor: 2.474

10.  Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee.

Authors:  Ian Adatia; Sheila G Haworth; Max Wegner; Robyn J Barst; Dunbar Ivy; Kurt R Stenmark; Abraham Karkowsky; Erika Rosenzweig; Christopher Aguilar
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.